stearyl trihydroxyethyl propylenediamine dihydrofluoride
Trade name: Olaflur
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Nov 1, 2008 (NCT01005966)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO.F.F- Mol. weight
- 498.78 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110901 ↗
- ChEMBLCHEMBL2106575 ↗
Also known as
- amine fluoride
- amine fluoride
- amine fluoride
- olaflur
- olaflur
- olaflur
- olaflur
- olaflur
- stearyl trihydroxyethyl propylenediamine dihydrofluoride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01317446 | Phase 4 | Nov 1, 2010 | Gaba International AG, Technical University of Dresden |
| NCT01005966 | Phase 3 | Nov 1, 2008 | GlaxoSmithKline |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gaba International AG | For profit | 1 | 0 | 1 | 2010 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2008 |
| Technical University of Dresden | Academic/Hospital | 1 | 1 | 1 | 2010 |
3 organizations
Page 1 / 1